Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants
- 1 June 1986
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 108 (6), 977-982
- https://doi.org/10.1016/s0022-3476(86)80943-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography-negative-ion chemical ionization mass spectrometryAnalytical Biochemistry, 1985
- Urinary Excretion Rates of 6-Keto-PGF1α, in Preterm Infants Recovering from Respiratory Distress with and without Patent Ductus ArteriosusPediatric Research, 1984
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- The Vasoactivity of the Fetal Lamb Ductus Arteriosus Studied in UteroPediatric Research, 1983
- Estimated rate of prostacyclin secretion into the circulation of normal man.Journal of Clinical Investigation, 1981
- EARLY PREDICTION OF SYMPTOMATIC PATENT DUCTUS ARTERIOSUS FROM PERINATAL RISK FACTORS: A DISCRIMINANT ANALYSIS MODELActa Paediatrica, 1981
- Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambsThe Journal of Pediatrics, 1980
- Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adultsThe Journal of Pediatrics, 1978
- Medical management of small preterm infants with symptomatic patient ductus arteriosusThe Journal of Pediatrics, 1978
- The critically ill premature infant with patent ductus arteriosus and pulmonary disease—an echocardiographic assessmentThe Journal of Pediatrics, 1975